Correlation Between Transgene and Aelis Farma

Can any of the company-specific risk be diversified away by investing in both Transgene and Aelis Farma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transgene and Aelis Farma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transgene SA and Aelis Farma SA, you can compare the effects of market volatilities on Transgene and Aelis Farma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transgene with a short position of Aelis Farma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transgene and Aelis Farma.

Diversification Opportunities for Transgene and Aelis Farma

0.0

Correlation Coefficient

Transgene  Aelis Farma

Pay attention - limited upside

The 3 months correlation between Transgene and Aelis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Transgene SA and Aelis Farma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aelis Farma SA and Transgene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transgene SA are associated (or correlated) with Aelis Farma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aelis Farma SA has no effect on the direction of Transgene i.e., Transgene and Aelis Farma go up and down completely randomly.

Pair Corralation between Transgene and Aelis Farma

If you would invest  0.00  in Transgene SA on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Transgene SA or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.4%
Values	Daily Returns

Transgene SA  vs.  Aelis Farma SA

Transgene SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Transgene SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Transgene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Aelis Farma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aelis Farma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Transgene and Aelis Farma

The main advantage of trading using opposite Transgene and Aelis Farma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transgene position performs unexpectedly, Aelis Farma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aelis Farma will offset losses from the drop in Aelis Farma's long position.

The idea behind Transgene SA and Aelis Farma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.